Performance indicators

As outlined in the "Internal control system" section, the following key performance indicators are utilized:

Financial performance indicators

Financial performance indicators 2025 2024
Sales revenues 505,079 KEUR 476,034 KEUR
EBIT 40,432 KEUR 42,815 KEUR
EBIT margin 8.0% 9.0%
Cash flow from operating activities 33,885 KEUR 53,105 KEUR

At the end of the third quarter, following a 5.9 % year-over-year increase in revenue, it was already becoming apparent that the slight increase in revenue forecast in the 2024 Annual Report for the 2025 fiscal year is likely to be achieved. Following a fourth quarter that also performed positively compared to the previous year (+6.6 %), the Uzin Utz Group achieved a 6.1 % increase in revenue for the full year 2025, with total revenue of EUR 505,079 thousand. The forecast of slight revenue growth was thus met. Furthermore, the stabilization of the construction industry in core and growth markets led to an uptick in revenue in 2025, following two years of stagnant revenue growth. For more detailed information regarding the revenue analysis, please refer to the "Profit situation" section.

The 2024 Group Management Report projected a slight decline in EBIT for 2025. As anticipated, this financial performance indicator decreased by 5.6 % to EUR 40,432 thousand (42,815). The cost of materials ratio remained stable in 2025, with a 0.2 percentage point increase, driven by relatively stable conditions in the procurement markets and raw material prices that remained at low levels. The German chemical industry has experienced an increase in personnel expenses due to workforce expansion and wage increases. There has also been a moderate rise in other operating expenses, primarily attributable to higher sales and advertising expenses, as well as operating and administrative costs. These factors have had a negative impact on earnings. Outbound freight costs remained stable relative to revenue, while the inbound freight ratio increased significantly due to higher U.S. tariffs. Negative currency effects also had a negative impact on EBIT. For more information on the analysis of earnings performance, please refer to the section on profit situation.

The EBIT margin contracted marginally by 1.0 percentage points, aligning with the forecast outlined in the 2024 Management Report. This decline can be attributed to a slight decrease in EBIT amid a slight increase in revenue.

Contrary to the forecast of a slight decline provided in the 2024 Group Management Report, cash flow from operating activities declined sharply, largely due to an increase in inventories and accounts receivable during the 2025 fiscal year.

Non-financial performance indicators

The non-financial performance indicators in the Group were as follows:

Non-financial key figures 2025 2024
Capacity utilization 89.1% 80.9%
Novelty ratio 23.7% 25.2%
Health ratio 95.4% 95.6%

The 2024 Group Management Report predicted that production capacity utilization would remain consistent. Contrary to the forecast, there was a significant increase in production capacity utilization in the 2025 reporting year, despite slight increases in capacity. This growth is primarily due to a substantial increase in capacity utilization in the dry mortar and dry adhesive segments, which subsequently led to higher production capacity utilization across the Group.

The Group's novelty ratio decreased from 25.2 % to 23.7 % in the 2025 reporting year, marking a slight decline. Contrary to the expectation of a moderate decline expressed in the 2024 Group Management Report, the decrease was thus smaller than forecast. This is primarily attributable to the high demand for FusionTec products, which made a significant contribution to revenue.

The health ratio within the Group remained at 95.4 % (95.6), which is roughly in line with the previous year's level. This is consistent with our forecast from the previous year, which did not anticipate any significant change. Consequently, the health ratio remains at a very high level.